Capital Fund Management (CFM)
BSX icon

Capital Fund Management (CFM)’s Boston Scientific BSX Stock Holding History

Capital Fund Management (CFM)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.01M Sell
48,000
-117,100
-71% -$9.37M 0.01% 1158
2025
Q4 		$15.7M Buy
165,100
+110,900
+205% +$10.9M 0.04% 592
2025
Q3 		$5.29M Buy
54,200
+10,300
+23% +$1.07M 0.01% 1216
2025
Q2 		$4.72M Buy
+43,900
New +$4.44M 0.01% 1172
2025
Q1 		– Sell
-39,300
Closed -$3.51M – 2006
2024
Q4 		$3.51M Sell
39,300
-62,100
-61% -$5.47M 0.01% 1252
2024
Q3 		$8.5M Buy
101,400
+11,800
+13% +$930K 0.02% 789
2024
Q2 		$6.9M Buy
89,600
+52,100
+139% +$3.81M 0.02% 825
2024
Q1 		$2.57M Buy
+37,500
New +$2.41M 0.01% 1335
2023
Q3 		– Sell
-33,700
Closed -$1.82M – 1937
2023
Q2 		$1.82M Sell
33,700
-55,700
-62% -$2.91M 0.01% 1221
2023
Q1 		$4.47M Buy
+89,400
New +$4.21M 0.02% 762
2022
Q1 		– Sell
-21,800
Closed -$926K – 1465
2021
Q4 		$926K Buy
+21,800
New +$916K 0.01% 1305
2020
Q4 		– Sell
-14,300
Closed -$546K – 1294
2020
Q3 		$546K Buy
+14,300
New +$551K 0.01% 1031
2020
Q2 		– Sell
-6,200
Closed -$202K – 1075
2020
Q1 		$202K Buy
+6,200
New +$242K ﹤0.01% 1410
2019
Q3 		– Sell
-10,100
Closed -$434K – 1675
2019
Q2 		$434K Buy
+10,100
New +$388K ﹤0.01% 1257
2018
Q4 		– Sell
-23,100
Closed -$889K – 1857
2018
Q3 		$889K Buy
23,100
+11,900
+106% +$416K ﹤0.01% 1414
2018
Q2 		$366K Buy
+11,200
New +$338K ﹤0.01% 1718
2015
Q3 		– Sell
-47,600
Closed -$843K – 1421
2015
Q2 		$843K Sell
47,600
-7,100
-13% -$127K 0.01% 880
2015
Q1 		$971K Buy
+54,700
New +$864K 0.01% 797
2014
Q1 		– Sell
-17,300
Closed -$208K – 1701
2013
Q4 		$208K Buy
+17,300
New +$204K ﹤0.01% 1567

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital Fund Management (CFM)'s BSX Position: Q1 2026 in Review

Capital Fund Management (CFM) increased its Boston Scientific (BSX) stake by 45% in Q1 2026, buying an estimated $41.1M and bringing the position to 1,665,947 shares worth $105M. The position accounts for 0.47% of the portfolio, ranked #17.

Capital Fund Management (CFM) first reported a position in BSX in Q2 2013 and has held it in 20 quarters since. The position peaked at $110M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Capital Fund Management (CFM) held 1,665,947 shares of Boston Scientific worth $105M as of Q1 2026.
  • Capital Fund Management (CFM) bought 513,899 Boston Scientific shares in Q1 2026, an estimated $41.1M.
  • Boston Scientific made up 0.47% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #17 holding.
  • Capital Fund Management (CFM) first reported a position in Boston Scientific in Q2 2013 and has held it in 20 quarters since.
  • Capital Fund Management (CFM)'s Boston Scientific position peaked at $110M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.